Clinical Trial Update: Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of fumaric acid esters (Fumaderm) for treating cutaneous lupus erythematosus has completed, reporting on effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Fumaderm (fumaric acid esters)

Snippet

Sponsor: University Hospital Muenster | Conditions: Lupus Erythematosus, Cutaneous | Phase 2 | Status: COMPLETED